Estudo observacional sugere que ceftarolina tem eficácia comparável à daptomicina no tratamento da infecção de corrente sanguínea por Staphylococcus aureus meticilina-resistente.
4 Fev, 2022 | 15:23h
Comentário no Twitter
New in OFID: A multicenter retrospective observational cohort study found no difference in treatment failure or mortality between MRSA bloodstream infections treated with ceftaroline or daptomycin.
📄: https://t.co/3QB5JXd8s5@PaulSaxMD @DrJLi @FungalDoc @IDpharmresearch pic.twitter.com/zNa9XRWP8F
— IDSA (@IDSAInfo) December 29, 2021


